PubMed Health⌕ Search

Biomedical subjects

M C Schell

Publications and source records attributed to M C Schell.

At least 19 recordsLinked to original sources
PubMed2000

Multi-objective optimization in radiotherapy: applications to stereotactic radiosurgery and prostate brachytherapy.

Treatment planning for radiation therapy is a multi-objective optimization process. Here we present a machine intelligent scheme for treatment planning based on multi-objective decision analysis (MODA) and genetic algorithm (GA) optimization. Multi-objective ranking strategies are represented in the L(p) metric under the displaced ideal model. Goal setting, protocol satisficing and fuzzy ranking of objective importance can be incorporated into the decision scheme to assimilate clinical decision making. For distance measures in the L(p) metric, a dynamic gauge function is defined based on the state energy of the decision system, which is assumed to undergo thermodynamic cooling with iteration time. The MODA scheme interacts with a robust GA engine, which adaptively evolves in the multi-modal landscape that defines the treatment plan quality. A conventionally challenging case of stereotactic radiosurgery of a brain lesion was selected for GA optimization. The resulting dose distributions are compared to human-developed plans, which are commonly regarded as clinically relevant and empirically optimal. The GA-optimized plans achieve substantially better sparing of critical normal neuroanatomy surrounding the brain lesion while respecting the preset constraints on tumor dose uniformity. In addition, machine optimization tends to produce novel treatment strategies which complements expert knowledge. The run time for producing an optimal plan is considerably shorter than the typical planning time for human experts, thus GA can also be used to aid the human treatment planning process. In prostate brachytherapy, MODA-GA was specifically applied to non-ideal conditions in which typical surgical uncertainties in seed implant positioning occur, where noisy objectives were introduced into the optimization scheme. The noisy system is found to be manageable by MODA-GA at uncertainty levels corresponding to reasonably proficient surgery teams. In contrast, noisy objectives would be very difficult to explore by human expert planners. Potential use of noisy optimization with time series analysis is being explored for error-corrective computer guidance in the operating room for prostate seed implantation. In conclusion, the combination of MODA and GA optimization offers both a solution to practical treatment planning tasks and the potential for real time applications in radiotherapy.

Algorithms↗
PubMed2000

Toward a statistically relevant calibration end point for prostate seed implants.

Interstitial brachytherapy for carcinoma of the prostate is achieved through the use of a configuration of radioactive seeds placed in a manner that delivers a customized, reasonably uniform dose to the target volume. Accurate dose delivery depends on both precise seed placement and reliable seed strength in the implanted configuration. This study assumes the independence of the two issues, and quantifies the reduction in the minimum dose to the surface of the gland due only to variability in individual seed strengths. Current AAPM guidelines pertaining to the acceptable limits on seed-to-seed variability are prudent for small configurations of seeds, yet are likely to be overly stringent for applications such as prostate seed implantation. In this study we determine the reduction in the minimum peripheral dose (mPD) caused by the introduction of source strength variability, and provide statistical insight into this effect. It is concluded that the current guidelines limit the reduction in mPD to < or =0.4% relative to the prescription value, for an average configuration, due to the inclusion of strength variability. The maximum observed reduction in mPD would be < or =1.5%. This value is an order of magnitude lower than the recommendations of the AAPM Task Group 40 for the overall accuracy of brachytherapy procedures, which suggests that seed strength variability is of limited concern and that constraints on this factor should perhaps be reevaluated.

Biophysical Phenomena↗
PubMed1999

Intraoperative optimized inverse planning for prostate brachytherapy: early experience.

PURPOSE: To demonstrate the feasibility of an intraoperative inverse planning technique with advanced optimization for prostate seed implantation. METHODS AND MATERIALS: We have implemented a method for optimized inverse planning of prostate seed implantation in the operating room (OR), based on the genetic algorithm (GA) driven Prostate Implant Planning Engine for Radiotherapy (PIPER). An integrated treatment planning system was deployed, which includes real-time ultrasound image acquisition, treatment volume segmentation, GA optimization, real-time decision making and sensitivity analysis, isodose and DVH evaluation, and virtual reality navigation and surgical guidance. Ten consecutive patients previously scheduled for implantation were included in the series. RESULTS: The feasibility of the technique was established by careful monitoring of each step in the OR and comparison with conventional preplanned implants. The median elapsed time for complete image capture, segmentation, GA optimization, and plan evaluation was 4, 10, 2.2, and 2 min, respectively. The dosimetric quality of the OR-based plan was shown to be equivalent to the corresponding preplan. CONCLUSION: An intraoperative optimized inverse planning technique was developed for prostate brachytherapy. The feasibility of the method was demonstrated through an early clinical experience.

Algorithms↗
PubMed1999

Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64.

There is now considerable evidence to suggest that technical innovations, 3D image-based planning, template guidance, computerized dosimetry analysis and improved quality assurance practice have converged in synergy in modern prostate brachytherapy, which promise to lead to increased tumor control and decreased toxicity. A substantial part of the medical physicist's contribution to this multi-disciplinary modality has a direct impact on the factors that may singly or jointly determine the treatment outcome. It is therefore of paramount importance for the medical physics community to establish a uniform standard of practice for prostate brachytherapy physics, so that the therapeutic potential of the modality can be maximally and consistently realized in the wider healthcare community. A recent survey in the U.S. for prostate brachytherapy revealed alarming variance in the pattern of practice in physics and dosimetry, particularly in regard to dose calculation, seed assay and time/method of postimplant imaging. Because of the large number of start-up programs at this time, it is essential that the roles and responsibilities of the medical physicist be clearly defined, consistent with the pivotal nature of the clinical physics component in assuring the ultimate success of prostate brachytherapy. It was against this background that the Radiation Therapy Committee of the American Association of Physicists in Medicine formed Task Group No. 64, which was charged (1) to review the current techniques in prostate seed implant brachytherapy, (2) to summarize the present knowledge in treatment planning, dose specification and reporting, (3) to recommend practical guidelines for the clinical medical physicist, and (4) to identify issues for future investigation.

Brachytherapy↗
PubMed1999

Radiochromic film dosimetry of a high dose rate beta source for intravascular brachytherapy.

Good clinical physics practice requires that dose rates of brachytherapy sources be checked by the institution using them, as recommended by American Association of Physicists in Medicine Task Group 56 and The American College of Radiology. For intravascular brachytherapy with catheter-based systems, AAPM Task Group 60 recommends that the dose rate be measured at a reference point located at a radial distance of 2 mm from the center of the catheter axis. AAPM Task Group 60 also recommends that the dose rate along the catheter axis at a radial distance of 2 mm should be uniform to within +/- 10% in the center two-thirds of the treated length, and the relative dose rate in the plane perpendicular to the catheter axis through the center of the source should be measured at distances from 0.5 mm to R90 (the distance from a point source within which 90% of the energy is deposited) at intervals of 0.5 mm. Radiochromic film dosimetry has been used to measure the dose distribution in a plane parallel to and at a radial distance of 2 mm from the axis of a novel, catheter-based, beta source for intravascular brachytherapy. The dose rate was averaged along a line parallel to the catheter axis at a radial distance of 2 mm, in the centered 24.5 mm of the treated length. This average dose rate agreed with the dose rate measured with a well ionization chamber by the replacement method using source trains calibrated with an extrapolation chamber at the National Institute of Standards and Technology. All of the dose rates in the centered 24.5 mm of a line parallel to the axis at a distance of 2 mm were within +/-10% of the average.

Beta Particles↗
PubMed1998

MR image-guided portal verification for brain treatment field.

PURPOSE: To investigate a method for the generation of digitally reconstructed radiographs directly from MR images (DRR-MRI) to guide a computerized portal verification procedure. METHODS AND MATERIALS: Several major steps were developed to perform an MR image-guided portal verification procedure. Initially, a wavelet-based multiresolution adaptive thresholding method was used to segment the skin slice-by-slice in MR brain axial images. Some selected anatomical structures, such as target volume and critical organs, were then manually identified and were reassigned to relatively higher intensities. Interslice information was interpolated with a directional method to achieve comparable display resolution in three dimensions. Next, a ray-tracing method was used to generate a DRR-MRI image at the planned treatment position, and the ray tracing was simply performed on summation of voxels along the ray. The skin and its relative positions were also projected to the DRR-MRI and were used to guide the search of similar features in the portal image. A Canny edge detector was used to enhance the brain contour in both portal and simulation images. The skin in the brain portal image was then extracted using a knowledge-based searching technique. Finally, a Chamfer matching technique was used to correlate features between DRR-MRI and portal image. RESULTS: The MR image-guided portal verification method was evaluated using a brain phantom case and a clinical patient case. Both DRR-CT and DRR-MRI were generated using CT and MR phantom images with the same beam orientation and then compared. The matching result indicated that the maximum deviation of internal structures was less than 1 mm. The segmented results for brain MR slice images indicated that a wavelet-based image segmentation technique provided a reasonable estimation for the brain skin. For the clinical patient case with a given portal field, the MR image-guided verification method provided an excellent match between features in both DRR-MRI and portal image. Moreover, target volume could be accurately visualized in the DRR-MRI and mapped over to the corresponding portal image for treatment verification. The accuracy of DRR-MRI was also examined by comparing it to the corresponding simulation image. The matching results indicated that the maximum deviation of anatomical features was less than 2.5 mm. CONCLUSION: A method for MR image-guided portal verification of brain treatment field was developed. Although the radiographic appearance in the DRR-MRI is different from that in the portal image, DRR-MRI provides essential anatomical features (landmarks and target volume) as well as their relative locations to be used as references for computerized portal verification.

Brain Neoplasms↗
PubMed1998

Quality assurance in linac-based stereotactic radiosurgery and radiotherapy.

Stereotactic Radiosurgery demands extraordinary attention to quality assurance issues. This is related to the high accuracy needed to perform a successful procedure, accuracy demanded by the proximity of the target lesion to neighboring fragile and eloquent structures in the head and large doses delivered. The nature of the linac-based radiosurgery procedure is that of a series of steps, each linked together and requiring quality control, for if one step is faulty the final result will be equally faulty. The salient points associated with the quality assurance of each step are laid out in this article. Implementation of a linac-based radiosurgery program in an institution must be well thought out and must be a team effort, involving expertise in medical physics, radiological imaging, radiation oncology, and specially trained radiation therapists in order to be successful and safe.

Brain Neoplasms↗
PubMed1997

Decision theoretic steering and genetic algorithm optimization: application to stereotactic radiosurgery treatment planning.

Treatment planning for stereotactic radiosurgery and fractionated radiotherapy is currently a labor intensive, operator-dependent process. Many degrees of freedom exist to make rigorous optimization intractable except by computationally intelligent techniques. The quality of a given plan is determined by an aggregate of clinical objectives, most of which are subject to competing tradeoffs. In this work, we present an autonomous scheme that couples decision theoretic guidance with a genetic algorithm for optimization. Ordinal ranking among a population of viable treatment plans is based on a generalized distance metric, which promotes a decreasing hyperfrontier of the efficient solution set. The solution set is driven toward efficiency by the genetic algorithm, which uses the tournament selection mechanism based on the ordinal ranking. Goals and satisficing conditions can be defined to signal the ultimate and the minimum achievement levels in a given objective. A conventionally challenging case in radiosurgery was used to demonstrate the practical utility and the problem-solving power of the decision theoretic genetic algorithm. Treatment plans with one isocenter and four isocenters were derived under the autonomous scheme and compared to the actual treatment plan manually optimized by the expert planner. Quality assessment based on dose-volume histograms and normal tissue complication probabilities suggested that computational optimization could be driven to offer varying degrees of dosimetric improvement over a human-guided optimization effort. Furthermore, it was possible to achieve a high degree of isodose conformity to the target volume in computational optimization by increasing the degree of freedom in the treatment parameters. The time taken to derive an efficient planning solution was comparable and usually shorter than in the manual planning process, and can be scaled down almost linearly with the number of processors. Overall, the autonomous genetic algorithm scheme was found to be powerful and versatile as a computationally intelligent counterpart to human-guided strategies in treatment optimization for stereotactic radiosurgery and radiotherapy.

Algorithms↗
PubMed1996

An observer study for direct comparison of clinical efficacy of electronic to film portal images.

PURPOSE: To directly compare clinical efficacy of electronic to film portal images. METHODS AND MATERIALS: An observer study was designed to compare clinical efficacy of electronic to film portal images acquired using a liquid matrix ion-chamber electronic portal imaging device and a conventional metal screen/film system. Both images were acquired simultaneously for each treatment port and the electronic portal images were printed on gray-level thermal paper. Four radiation oncologists served as observers and evaluated a total of 44 sets of images for four different treatment sites: lung, pelvis, brain, and head/neck. Each set of images included a simulation image, a double-exposure portal film, and video paper prints of electronic portal images. Eight to nine anatomical landmarks were selected from each treatment site. Each observer was asked to rate each landmark in terms of its clinical visibility and to rate the ease of making the pertinent verification decision in the corresponding electronic and film portal images with the aid of the simulation image. RESULTS: Ratings for the visibility of landmarks and for the verification decision of treatment ports were similar for electronic and film images for most landmarks. However, vertebral bodies and several landmarks in the pelvis such as the acetabulum and public symphysis were more visible in the portal film images than in the electronic portal images. CONCLUSION: The visibility of landmarks in electronic portal images is comparable to that in film portal images. Verification of treatment ports based only on electronic portal images acquired using an electronic portal imaging device is generally achievable.

Observer Variation↗
PubMed1996

A genetic algorithm for the optimization of prostate implants.

A genetic algorithm (GA) is presented for the optimization of template- and ultrasound-guided prostate implants. The end points for optimization are incorporated in an objective function of separable cardinal utility terms. As an application of the GA, the minimum 103Pd total source strength required to deliver a given dose was correlated with the average dimension for prostate implants carried out under the current template and seed spacing protocols. Significant improvements in quality were observed, in terms of both the minimum peripheral dose and tumor cell surviving fractions, when GA-optimized implants were compared to the corresponding unoptimized implants for given target volumes. In addition, numerical simulation of source displacements indicates that the dosimetric and radiobiologic advantages of GA optimization can tolerate a reasonable level of seed placement uncertainties observed clinically. In summary, the GA application provides an automated design strategy for prostate implant planning, and at the same time affords the potential for systematic optimization of a set of end points that can sustain practical variations.

Algorithms↗
PubMed1995

Dose-volume histogram analysis of techniques for irradiating pituitary adenomas.

PURPOSE: Three-dimensional treatment planning was performed to evaluate three standard coplanar irradiation techniques (two-field parallel-opposed, three-field, and 110 degrees bilateral arcs), the 330 degrees single rotational arc, and a four noncoplanar arc technique for the treatment of pituitary adenomas. We sought to identify the optimal technique for minimizing the dose delivered to the normal tissues around the pituitary gland. METHODS AND MATERIALS: Contours of the pituitary tumor and normal tissues were traced onto computed axial tomography (CT) scans and reconstructed in three dimensions using a three-dimensional planning system. A total dose of 45 Gy was delivered to the pituitary lesion with the five techniques using 6 MV and 18 MV photons, and dose-volume histograms were generated. RESULTS: The 18 MV photons delivered a lower dose to the temporal lobe than did the 6 MV photons in the two-field technique, but this advantage was not evident for the other techniques. The three-field technique improved dose distribution throughout the temporal lobes with low doses being delivered to the frontal lobe. The bilateral arc and the 330 degrees arc techniques were superior to stationary two- and three-fields techniques for sparing the temporal lobes. The four noncoplanar arc technique delivered less doses to the temporal and frontal lobes than did the other techniques. However, the lens dose (3.6 Gy/25 fractions) was higher compared to the other techniques. CONCLUSION: Analysis of the dose-volume histograms shows the various dosimetric advantages and disadvantages of the five techniques. Based upon individual considerations, including the patient's age and medical history, one can decide the optimal technique for treatment.

Humans↗
PubMed1995

Three-dimensional conformal pancreas treatment: comparison of four- to six-field techniques.

PURPOSE: We compare practical conformal treatment approaches to pancreatic cancer using 6 and 18 MV photons and contrast those approaches against standard techniques. METHODS AND MATERIALS: A four-field conformal technique for treating pancreas cancer has been developed using nonopposed 18 MV photons. This approach has been extended to 6 MV photon application by the addition of one to two fields. These techniques have been optimized to increase sparing of normal liver and bowel, compared with opposed-field methods, to improve patient tolerance of high doses. In this study we compare these techniques in a simulated tumor model in a cylindrical phantom. Dose-volume analysis is used to quantify differences between the conformal, nonopposed techniques with conformal, opposed field methods. This model is also used to evaluate the effect of 1-2 cm setup errors on dose-volume coverage. RESULTS: Dose-volume analysis demonstrates that five-to-six field conformal treatments using 6 MV photons provides similar or better dose coverage and normal tissue sparing characteristics as an optimized 18 MV, four-field approach when 1-2 cm margins are included for setup uncertainty. All approaches using nonopposed beam geometry provide significant reduction in the volume of tissue encompassed by the 30-50% isodose surfaces, as compared with four-field box techniques. CONCLUSIONS: Three-dimensional (3D) conformal treatments can be designed that significantly improve dose-volume characteristics over conventional treatment designs without costing unacceptable amounts of machine time. Further, deep intraabdominal sites can be adequately accessed and treated on intermediate energy machines with a relatively moderate increase in machine time.

Humans↗
PubMed1994

Uniform irradiation of the craniospinal axis with a penumbra modifier and an asymmetric collimator.

PURPOSE: A technique is described that uses an independent, asymmetric collimator and a penumbra modifier to uniformly administer radiation over the craniospinal axis. METHOD AND MATERIALS: An isocenter is used at the junction of the cranial and the upper spinal fields. These fields are defined by a single isocenter at spinal cord depth and an independent, asymmetric collimator. From the isocenter, the cranial and upper spinal fields are extended 1 cm inferiorly and superiorly, respectively. A modifier provides a 2-cm wide penumbra at the central axis of the beam (overlapping region) and is attached to a wedge tray in an accessory slot. This modifier allows the fields to be matched so a uniform dose is delivered over the isocenter and junction. Dose distribution was measured with an anthropomorphic head-and-neck wax phantom that included the seventh cervical vertebrae. A film was placed in a coronal cut at the spinal cord level. RESULTS: The administered dose varied less than 10% through the craniospinal axis. Reproducibility with portal films has been very good. Advantages include dose homogeneity, easy reproducibility, and decreased setup time. CONCLUSION: This single-field isocentric technique allows more uniform irradiation of the craniospinal axis than do previously described techniques.

Head and Neck Neoplasms↗
PubMed1994

Input/output characteristics of a matrix ion-chamber electronic portal imaging device.

The input/output characteristics of a matrix liquid ion-chamber electronic portal imaging device (EPID) are investigated to elucidate the imaging properties of EPIDs. The radiation input to the detector, represented by dose rate, and the pixel value output from the device are related by a characteristic curve. Various incident radiation intensities are obtained by changing the source-to-detector distance (SDD). For each incident radiation intensity, an electronic portal image is obtained using a field size of 5 x 5 cm2. The output pixel value of the EPID is represented by the average pixel value of a region of interest of 9 x 9 pixels centered at a selected point. The effects of various accelerator settings, such as the repetition-rate setting and photon energy, gantry angle, field size, SDD, and acquisition mode of the EPID on characteristic curves are investigated at the central axis. The off-axis response of the detector is also examined. The derivative of the pixel value with respect to the input dose rate is used to analyze the detector contrast. Results indicate that the output pixel value is not a linear function of the incident radiation intensity. The detector contrast is comparable between photon energies of 10 and 6 MV and increases at low dose rates. The response of the imaging device varies substantially with acquisition mode, but is less sensitive to the SDD used for calibration. Characteristic curves are consistent for different gantry angles at the central axis and with the off-axis locations when the gantry angle is used for imaging and calibration, but vary with off-axis locations when the gantry angle is not at the calibration direction. Characteristic curves are also found to vary with different field sizes, but are similar in shape.

Humans↗
PubMed1994

A technique of automating compensator design for lung inhomogeneity correction using an electron portal imaging device.

A technique of automating compensator design for lung inhomogeneity correction using an electron portal imaging device (EPID) has been investigated. This technique utilizes exit-radiation information as detected by an EPID to determine the thickness of the compensator desired. In this particular study, the compensator thickness is determined to provide a uniform gray-level distribution (related to uniform exit-dose distribution) in the region of the portal image to be compensated. Initially, a compensation characteristic curve, which relates the compensator thickness to the pixel value of the electronic portal image, is measured for both the Lead and Lipowitz compensator materials and a 6-MV photon beam. Then, a chest-treatment field is simulated using an anthropomorphic phantom. Based on the analysis of the profile (gray-level distribution) across the lung and mediastinum regions in the electronic portal image, the average of pixel values within the mediastinum region is selected as the matching level and the regions to be compensated are determined. With the aid of the predetermined compensation characteristic curve and proper distance scaling, the compensator thickness at each pixel location is automatically calculated at the block tray level to correct lung inhomogeneity. In a simple test using a single anterioposterior (AP) chest field, the compensated profile in the electronic portal image presents a uniform gray-level distribution (related to uniform exit dose) compared to the uncompensated profile.(ABSTRACT TRUNCATED AT 250 WORDS)

Biophysical Phenomena↗